Literature DB >> 28985909

Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer.

Iris G Insogna1, Malinda S Lee2, Rebecca M Reimers3, Thomas L Toth3.   

Abstract

OBJECTIVE: To examine the effects of body mass index (BMI) on implantation rate after uniform protocol frozen-thawed blastocyst transfer in women with a homogenous uterine environment.
DESIGN: Retrospective cohort study.
SETTING: Single IVF clinic at a large academic institution. PATIENT(S): Four hundred sixty-one infertile women treated at a large academic institution from January 2007 to January 2014. INTERVENTION(S): All women underwent standardized slow frozen-thawed blastocyst transfers with good-quality day 5-6 embryos, following an identical hormonal uterine preparation, with comparison groups divided according to BMI category: underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese (≥30.0 kg/m2). MAIN OUTCOME MEASURE(S): Implantation rate. RESULT(S): There were no statistically significant differences identified when comparing implantation rates among the four BMI cohorts. The implantation rate was 38.2% in normal weight patients, 41.7% in underweight patients, 45.1% in overweight patients, and 34.7% in obese patients. Adjusted odds ratios (OR) demonstrated no association between the main outcome, implantation rate, and BMI. Compared with the normal weight patients, the adjusted OR of implantation was 1.70 (95% confidence interval [CI], 0.40-7.72) for underweight patients, 1.61 (95% CI, 0.97-2.68) for overweight patients, and 0.92 (95% CI, 0.49-1.72) for obese patients. Secondary outcomes, including rates of miscarriage, clinical pregnancy, ongoing pregnancy, and live birth, were not significantly different between cohorts. While powered to detect a 16% difference between overweight and normal weight women, the study was underpowered to detect differences in the underweight and obese women, and no definitive conclusions can be drawn for these small cohorts. Patients with transfers that required the longest amount of time, greater than 200 seconds, had the highest average BMI of 27.5 kg/m2. CONCLUSION(S): Under highly controlled circumstances across 7 years of data from a single institution, using a uniform uterine preparation, following a precise transfer technique with high-quality day 5-6 slow frozen-thawed blastocysts, a BMI in the overweight range of 25-29.9 kg/m2 is not associated with a poorer implantation rate or live-birth rate, nor is it associated with an increased risk of miscarriage when compared with a normal BMI range. The increased length of time required during transfer for women with higher BMI suggests body habitus may contribute to difficult transfers, although this may not translate into poorer implantation rates. By using a standardized protocol for slow freezing and thawing of embryos, using identical hormonal preparation and a uniform ET protocol, a homogenous uterine environment was created in this carefully selected cohort of women, thereby minimizing confounders and uniquely highlighting the neutral effect of overweight BMI on implantation rate.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frozen-thawed embryo transfer; body mass index; implantation rate

Mesh:

Year:  2017        PMID: 28985909     DOI: 10.1016/j.fertnstert.2017.08.024

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  The influence of body mass index on pregnancy outcome following single-embryo transfer.

Authors:  Avi Ben-Haroush; Ido Sirota; Lina Salman; Weon-Young Son; Togas Tulandi; Hananel Holzer; Galia Oron
Journal:  J Assist Reprod Genet       Date:  2018-05-28       Impact factor: 3.412

2.  Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China.

Authors:  Jie Zhang; Hongfang Liu; Xiaoyan Mao; Qiuju Chen; Yong Fan; Yitao Xiao; Yun Wang; Yanping Kuang
Journal:  BMC Med       Date:  2019-06-26       Impact factor: 8.775

3.  Does body mass index impact assisted reproductive technology treatment outcomes in gestational carriers.

Authors:  Noga Fuchs Weizman; Miranda K Defer; Janice Montbriand; Julia M Pasquale; Adina Silver; Clifford L Librach
Journal:  Reprod Biol Endocrinol       Date:  2020-05-02       Impact factor: 5.211

4.  Body mass index is associated with miscarriage rate and perinatal outcomes in cycles with frozen-thawed single blastocyst transfer: a retrospective cohort study.

Authors:  Yu Zheng; Xiyuan Dong; Biao Chen; Jun Dai; Wei Yang; Jihui Ai; Lei Jin
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-11       Impact factor: 3.007

5.  Inflammatory and metabolic markers in relation to outcome of in vitro fertilization in a cohort of predominantly overweight and obese women.

Authors:  Henrik Svensson; Snorri Einarsson; Daniel Olausson; Linda Kluge; Christina Bergh; Staffan Edén; Malin Lönn; Ann Thurin-Kjellberg
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

6.  Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer.

Authors:  Rui Chen; Shiping Chen; Manting Liu; Hua He; Haiyan Xu; Hanyan Liu; Hongzi Du; Weihua Wang; Xuefeng Xia; Jianqiao Liu
Journal:  Reprod Biol Endocrinol       Date:  2018-04-10       Impact factor: 5.211

7.  Major Factors Affecting the Live Birth Rate After Frozen Embryo Transfer Among Young Women.

Authors:  Ye Pan; Guimin Hao; Qiumin Wang; Hong Liu; Ze Wang; Qi Jiang; Yuhua Shi; Zi-Jiang Chen
Journal:  Front Med (Lausanne)       Date:  2020-03-24

8.  Association between abnormal body mass index and pregnancy outcomes in patients following frozen embryo transfer: a systematic review and meta-analysis.

Authors:  Jiaqi Yang; Yichen He; Yiqing Wu; Dan Zhang; Hefeng Huang
Journal:  Reprod Biol Endocrinol       Date:  2021-09-09       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.